DNA

Triple Board-Certified Surgeon and Hair Transplant Expert Dr. Jason Dudas Joins the Aesthetic Surgery Center in Naples, FL

Leading hair transplant surgeon Dr. Jason Dudas brings cutting-edge techniques to Naples.NAPLES, FL / ACCESSWIRE / October 23, 2024 /…

1 year ago

Access Genetics Acquires Breakthrough Point-of-Care Rapid PCR Technology

Patent-pending real-time quantitative PCR testing platform was acquired by Access Genetics from Sensible Diagnostics. EDEN PRAIRIE, Minn., Oct. 22, 2024…

1 year ago

Dotmatics Introduces Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery

The first in a series of Dotmatics Luma Multimodal R&D Solutions Geneious has been seamlessly composed into Luma showcasing cross-therapeutic…

1 year ago

Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184

Company to conduct a Phase 1 Drug-Drug Interaction StudyPhase 2 filing on track for Q1 2025 SOUTH SAN FRANCISCO, Calif.,…

1 year ago

Awakn Announces Opening of Four Additional AWKN-001 Phase 3 Trial Sites

Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…

1 year ago

Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024

SALT LAKE CITY, Oct. 21, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company…

1 year ago

HuidaGene Therapeutics Appoints TJ Cradick, PhD as Chief Technology Officer to Lead Delivery Science and Genome Editing Innovations

SHANGHAI and MIDDLETOWN, Del., Oct. 21, 2024 /PRNewswire/ -- HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company pioneering CRISPR-based programmable genome medicines,…

1 year ago

Nurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia

NX-5948 demonstrated robust clinical activity with objective responses observed in 7 of 9 (77.8%) evaluable Waldenstrom’s patients in the ongoing…

1 year ago

Legacy and Posterity Health Announce Innovative Partnership to Increase Access to Male Fertility Care

NEW YORK, Oct. 18, 2024 /PRNewswire/ -- Legacy, the country's leading sperm testing and freezing company, and Posterity Health, the…

1 year ago

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

HOUSTON, Oct. 18, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) (“FibroBiologics”) and Charles River Laboratories (“Charles River”), a leading…

1 year ago